Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
167.58B
Market cap167.58B
Price-Earnings ratio
9.16
Price-Earnings ratio9.16
Dividend yield
3.28%
Dividend yield3.28%
Average volume
14.63M
Average volume14.63M
High today
$38.17
High today$38.17
Low today
$37.46
Low today$37.46
Open price
$37.57
Open price$37.57
Volume
4.54M
Volume4.54M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

The Motley Fool 15h
Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?

Novo Nordisk (NVO -0.03%) has seen both sides of the emotional swings investors often experience. Enthusiastic investors pushed its stock higher by more than 20...

Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?
TipRanks 23h
Novo Nordisk Probes Patient Priorities in German Hemophilia A Study

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk Tests What Matters Most to Hemophilia A Patients in Germany. This study, t...

TipRanks 1d
Novo Nordisk Expands Treasury Stake as DKK 15bn Buyback Nears DKK 10bn Mark

Novo Nordisk ( (NVO) ) has shared an update. Novo Nordisk has continued executing its DKK 15 billion, 12‑month share repurchase programme launched on 4 Februar...

Analyst ratings

50%

of 6 ratings
Buy
16.7%
Hold
50%
Sell
33.3%

More NVO News

Zacks 1d
Is Most-Watched Stock Novo Nordisk A/S Worth Betting on Now?

Novo Nordisk (NVO Quick QuoteNVO - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some...

Is Most-Watched Stock Novo Nordisk A/S Worth Betting on Now?
TipRanks 2d
Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares down 18c near $37.15. Options volume relatively light with 24k contracts traded and c...

The Motley Fool 5d
Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors

Novo Nordisk (NVO -0.21%) is looking to maintain its position in the weight-loss market and one-up its most important competitor, Eli Lilly (LLY -0.61%). To tha...

Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors
TipRanks 5d
Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Volume at Dosing...

The Motley Fool 5d
Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

As the global healthcare landscape shifts toward weight-loss treatments and chronic care, investors are weighing two giants. Should you invest in Novo Nordisk A...

Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Simply Wall St 5d
Novo Nordisk Stock Looks Reasonable Given Uncertain Long Term Earnings

has seen a steep share price reset in recent years, and the question now is whether the current valuation still lines up with the earnings power investors are p...

Novo Nordisk Stock Looks Reasonable Given Uncertain Long Term Earnings
Benzinga 6d
Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports

Novo Nordisk A/S (NYSE:NVO) on Thursday presented a post hoc analysis from a STEP UP trial sub-population, indicating that Wegovy (pooled semaglutide 7.2 and 2....

Over 88% Of Wegovy Trial Participants Achieve Normal Liver Fat Levels, Novo Reports

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.